Brief: Ambu Q3 Adjusted EBIT DKK 178 Million Vs. Estimate DKK 178 Million
30/08/2024 06:00
Aug 30 (Reuters) - Ambu Q3 adjusted EBIT margin 12.9% vs. estimate 12.9%. * outlook FY adjusted EBIT margin 11-13% * outlook FY organic growth 12-14%
Recent news on Ambu A/S
See all newsBrief: Ambu Says Two Bronchoscopes Get FDA Clearance, CE Mark For Use In Pediatric Airway Procedures
Brief: Ambu Obtains Regulatory Clearances For Expanded GI Indication
UBS turns cautious on Ambu's targets, cuts to 'neutral'
Brief: Ambu Acquires TIMS Medical To Advance Endointelligence
Brief: Ambu Reports Q3 EBIT DKK 221 Mln